Viral hepatitis – i.e. HBV and HCV continues to rise amongst drug users and patterns of injecting drug use are changing. Equally, the number of sexually transmitted infection (STI) notifications increase year on year.
It is therefore time to question the efficacy of current interventions. Harm reduction services continue to play a vital role in public health, in minimising the spread of blood borne viruses (and STIs).
This one-day training module introduces participants to the key issues surrounding blood borne virus infection: prevention; transmission; screening; vaccination and treatment.
- To understand concept of harm reduction in relation to BBVs
- To provide an overview of the Health Protection Agency: "Shooting Up" Report - November, 2013
- To understand BBVs - their effects and prevalence
- To understand the changing patterns of drug use
- To identify effective prevention and treatment interventions with people who inject drugs
- To improve knowledge re: treatment options & vaccinations
- To understand HIV and Viral Hepatitis disease progression
- To enable good practice and awareness of screening issues
- To enable confidence in assessment, and asking questions around BBVs and risk factors
- To improve professional practice and enable identification of local care pathways